Lifevantage (LFVN) EBITDA (2010 - 2026)

Lifevantage has reported EBITDA for 17 years, with the latest figure at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA fell 66.63% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $5.6 million (down 40.3% YoY), and the FY2025 full-year result was $10.5 million, up 342.74% from the prior year.
• EBITDA for Q1 2026 stood at $1.2 million, up from $17000.0 in the prior quarter.
• The five-year high for EBITDA was $3.7 million in Q1 2025, with the low at -$2.0 million in Q2 2022.
• Historically, EBITDA has averaged $1.0 million across 5 years, with a median of $1.1 million in 2024.
• Annual changes were most pronounced in 2022 — EBITDA sank 318.0% — and 2024, when it surged 1068.91%.
• Lifevantage's EBITDA stood at -$418000.0 in 2022, then surged by 53.83% to -$193000.0 in 2023, then surged by 1068.91% to $1.9 million in 2024, then tumbled by 99.09% to $17000.0 in 2025, then jumped by 7217.65% to $1.2 million in 2026.
• The last three EBITDA figures came in at $1.2 million (Q1 2026), $17000.0 (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.